Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Tags

acquisition

12/31/2023 - 02:10 PM

BOSTON--(BUSINESS WIRE)-- Boston Millennia Partners (“Boston Millennia”), a significant shareholder of SomaLogic (the “Company”) (Nasdaq: SLGC) today announced that it intends to vote against the Company’s planned merger (the “Merger”) with Standard BioTools Inc. (Nasdaq: LAB).

View source version on businesswire.com: https://www.businesswire.com/news/home/20231231077712/en/

Amy Merk

amy@bmpvc.com

Source: Boston Millennia Partners

Somalogic, Inc.

NASDAQ:SLGC

SLGC Rankings

#4641 Ranked by Market Cap

N/A Ranked by Dividends

SLGC Latest News

Mar 5, 2024

OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024

Jan 4, 2024

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

Jan 4, 2024

Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting

Jan 4, 2024

Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools

Jan 2, 2024

SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools

SLGC Stock Data

Market Cap 396.23M

Float 175.53M

Insiders Ownership 2.16%

Institutions Ownership 61.71%

Short Percent 3.79%

Industry Health Information Services

Sector Healthcare

Website Link

Country United States

City Boulder